Mylan Drops Appeal In Generic Paxil Contract Fight
By Pete Brush ( November 2, 2010, 5:11 PM EDT) -- Mylan Inc. has dropped its nascent appeal of a judge's refusal to enjoin Apotex Corp. from making a copycat version of Paxil CR and entered a discovery plan to litigate its claim that a previous agreement with GlaxoSmithKline PLC gives it the exclusive right to sell a generic form of the antidepressant....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.